Summary of the muscle phenotypes observed at different developmental stages in XHas2 and XCD44 loss of function experiments
. | Stages 17-18 . | . | Stages 22-24 . | . | Stages 30-37 . | . | |||
---|---|---|---|---|---|---|---|---|---|
. | XHas2-Mo . | XCD44-Mo . | XHas2-Mo . | XCD44-Mo . | XHas2-Mo . | XCD44-Mo . | |||
MyoD | * | * | |||||||
p27 | − | * | |||||||
CA | − | * | − | * | − | * | |||
Apoptotic rate | + | * | * | * | * | * | |||
Muscle mass | − | * | − | * | |||||
Hypaxial cell migration | − | − |
. | Stages 17-18 . | . | Stages 22-24 . | . | Stages 30-37 . | . | |||
---|---|---|---|---|---|---|---|---|---|
. | XHas2-Mo . | XCD44-Mo . | XHas2-Mo . | XCD44-Mo . | XHas2-Mo . | XCD44-Mo . | |||
MyoD | * | * | |||||||
p27 | − | * | |||||||
CA | − | * | − | * | − | * | |||
Apoptotic rate | + | * | * | * | * | * | |||
Muscle mass | − | * | − | * | |||||
Hypaxial cell migration | − | − |
*, normal; −, reduced; + increased.
The number of processed embryos is provided in the text.